ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
Mural Oncology
2.58
+0.0700
2.79%
盘后:
2.60
0.0200
+0.78%
16:05 EDT
成交量:
12.72万
成交额:
32.96万
市值:
4,455.37万
市盈率:
-0.34
高:
2.64
开:
2.55
低:
2.55
收:
2.51
数据加载中...
总览
公司
新闻资讯
公告
Mural Oncology Plc盘中异动 股价大涨5.06%报2.64美元
市场透视
·
07-03
Mural Oncology Plc5月16日成交额为57.65万美元
市场透视
·
05-17
Mural Oncology Plc5月14日成交额为19.82万美元
市场透视
·
05-15
Mural Oncology Plc5月12日成交额为81.91万美元
市场透视
·
05-13
Mural Oncology Plc5月8日成交额为114.16万美元
市场透视
·
05-09
Mural Oncology Plc5月7日成交额为36.97万美元
市场透视
·
05-08
Mural Oncology Plc5月6日成交额为113.27万美元
市场透视
·
05-07
Mural Oncology Plc5月2日成交额为93.40万美元
市场透视
·
05-03
Mural Oncology Plc4月30日成交额为92.49万美元
市场透视
·
05-01
Mural Oncology Plc4月29日成交额为105.38万美元
市场透视
·
04-30
Mural Oncology Plc4月28日成交额为118.95万美元
市场透视
·
04-29
Mural Oncology Plc4月25日成交额为113.38万美元
市场透视
·
04-26
Mural Oncology Plc4月24日成交额为209.89万美元
市场透视
·
04-25
Mural Oncology Plc4月22日成交额为321.75万美元
市场透视
·
04-23
Mural Oncology Plc盘中异动 股价大跌5.19%报2.56美元
市场透视
·
04-21
本周解锁数据一览:UDS、VENOM及MURA等代币将于本周迎来一次性大额解锁
Blockbeats
·
04-21
Mural Oncology Plc4月17日成交额为1520.35万美元
市场透视
·
04-18
Mural Oncology Plc盘中异动 早盘股价大涨5.58%报2.56美元
市场透视
·
04-17
Mural Oncology Plc4月16日成交额为1980.46万美元
市场透视
·
04-17
Mural Oncology Plc4月15日成交额为6.93亿美元
市场透视
·
04-16
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/MURA/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MURA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MURA\",,,,,undefined,":{"symbol":"MURA","market":"US","secType":"STK","nameCN":"Mural Oncology","latestPrice":2.58,"timestamp":1751562000000,"preClose":2.51,"halted":0,"volume":127240,"hourTrading":{"tag":"盘后","latestPrice":2.6,"preClose":2.58,"latestTime":"16:05 EDT","volume":235,"amount":610.62,"timestamp":1751573121036},"delay":0,"floatShares":10382267,"shares":17268881,"eps":-7.668418,"marketStatus":"休市中","change":0.07,"latestTime":"07-03 13:00:00 EDT","open":2.55,"high":2.6369,"low":2.55,"amount":329642.4637,"amplitude":0.034622,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.668418,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1751875200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":2.51,"preHourTrading":{"tag":"盘前","latestPrice":2.53,"preClose":2.51,"latestTime":"08:53 EDT","volume":1477,"amount":3782.2699921999997,"timestamp":1751547197153},"postHourTrading":{"tag":"盘后","latestPrice":2.6,"preClose":2.58,"latestTime":"16:05 EDT","volume":235,"amount":610.62,"timestamp":1751573121036},"volumeRatio":4.233270574232051,"impliedVol":0.4267,"impliedVolPercentile":0.26},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MURA\",,,,,undefined,":{"symbol":"MURA","floatShares":10382267,"roa":"-43.80%","roe":"-76.27%","lyrEps":-7.5799,"volumeRatio":4.233270574232051,"shares":17268881,"dividePrice":0,"high":2.6369,"amplitude":0.034622,"preClose":2.51,"low":2.55,"week52Low":0.95,"pbRate":"0.41","week52High":4.74,"institutionHeld":0,"latestPrice":2.58,"eps":-7.668418,"divideRate":0,"volume":127240,"delay":0,"ttmEps":-7.668418,"open":2.55,"prevYearClose":3.22,"prevWeekClose":2.48,"prevMonthClose":2.47,"prevQuarterClose":2.47,"fiveDayClose":2.48,"twentyDayClose":2.59,"sixtyDayClose":1.16},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MURA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2548383946","title":"Mural Oncology Plc盘中异动 股价大涨5.06%报2.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548383946","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548383946?lang=zh_cn&edition=fundamental","pubTime":"2025-07-03 22:48","pubTimestamp":1751554095,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日22时48分,Mural Oncology Plc股票出现异动,股价急速上涨5.06%。截至发稿,该股报2.64美元/股,成交量2.9117万股,换手率0.17%,振幅3.19%。Mural Oncology Plc股票所在的生物技术行业中,整体涨幅为0.63%。Mural Oncology Plc公司简介:Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703224815a72cf763&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703224815a72cf763&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2536837601","title":"Mural Oncology Plc5月16日成交额为57.65万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536837601","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536837601?lang=zh_cn&edition=fundamental","pubTime":"2025-05-17 10:37","pubTimestamp":1747449479,"startTime":"0","endTime":"0","summary":"美东时间2025年5月16日,Mural Oncology Plc成交额为57.65万美元,成交额较昨日增加89.52%,当日成交量为22.20万股。Mural Oncology Plc于2025年5月16日涨4.74%,报2.65美元,该股过去5个交易日涨0.76%,年初至今跌17.7%,过去60日跌37.2%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-16|57.65万|89.52%|22.20万|#|2025-05-15|30.42万|53.45%|12.17万|#|2025-05-14|19.82万|-49.74%|7.60万|#|2025-05-13|39.44万|-51.85%|14.77万|#|2025-05-12|81.91万|16.68%|31.31万|Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517103808a6e252f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517103808a6e252f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2535300558","title":"Mural Oncology Plc5月14日成交额为19.82万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535300558","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535300558?lang=zh_cn&edition=fundamental","pubTime":"2025-05-15 10:35","pubTimestamp":1747276545,"startTime":"0","endTime":"0","summary":"美东时间2025年5月14日,Mural Oncology Plc成交额为19.82万美元,成交额较昨日减少49.74%,当日成交量为7.60万股。Mural Oncology Plc于2025年5月14日跌3.76%,报2.56美元,该股过去5个交易日涨1.19%,年初至今跌20.5%,过去60日跌40.6%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-14|19.82万|-49.74%|7.60万|#|2025-05-13|39.44万|-51.85%|14.77万|#|2025-05-12|81.91万|16.68%|31.31万|#|2025-05-09|70.20万|-38.51%|27.00万|#|2025-05-08|114.16万|208.82%|44.87万|Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515103550a6dfba6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515103550a6dfba6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2535752983","title":"Mural Oncology Plc5月12日成交额为81.91万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535752983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535752983?lang=zh_cn&edition=fundamental","pubTime":"2025-05-13 10:30","pubTimestamp":1747103445,"startTime":"0","endTime":"0","summary":"美东时间2025年5月12日,Mural Oncology Plc成交额为81.91万美元,成交额较昨日增加16.68%,当日成交量为31.31万股。Mural Oncology Plc于2025年5月12日涨0.38%,报2.64美元,该股过去5个交易日涨3.94%,年初至今跌18.01%,过去60日跌38.03%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-12|81.91万|16.68%|31.31万|#|2025-05-09|70.20万|-38.51%|27.00万|#|2025-05-08|114.16万|208.82%|44.87万|#|2025-05-07|36.97万|-67.36%|14.61万|#|2025-05-06|113.27万|20.51%|44.85万|Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513103046a6dcebba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513103046a6dcebba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2534211907","title":"Mural Oncology Plc5月8日成交额为114.16万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534211907","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534211907?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 10:15","pubTimestamp":1746756902,"startTime":"0","endTime":"0","summary":"美东时间2025年5月8日,Mural Oncology Plc成交额为114.16万美元,成交额较昨日增加208.82%,当日成交量为44.87万股。Mural Oncology Plc于2025年5月8日涨2.37%,报2.59美元,该股过去5个交易日跌0.77%,年初至今跌19.57%,过去60日跌37.89%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-08|114.16万|208.82%|44.87万|#|2025-05-07|36.97万|-67.36%|14.61万|#|2025-05-06|113.27万|20.51%|44.85万|#|2025-05-05|93.99万|0.63%|36.68万|#|2025-05-02|93.40万|-7.82%|35.64万|Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509101508a6d87103&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509101508a6d87103&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2533728912","title":"Mural Oncology Plc5月7日成交额为36.97万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533728912","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533728912?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 10:10","pubTimestamp":1746670255,"startTime":"0","endTime":"0","summary":"美东时间2025年5月7日,Mural Oncology Plc成交额为36.97万美元,成交额较昨日减少67.36%,当日成交量为14.61万股。Mural Oncology Plc于2025年5月7日涨0.8%,报2.53美元,该股过去5个交易日跌3.8%,年初至今跌21.43%,过去60日跌40.89%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-07|36.97万|-67.36%|14.61万|#|2025-05-06|113.27万|20.51%|44.85万|#|2025-05-05|93.99万|0.63%|36.68万|#|2025-05-02|93.40万|-7.82%|35.64万|#|2025-05-01|101.32万|9.55%|38.98万|Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508101104a4760e0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508101104a4760e0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2533617370","title":"Mural Oncology Plc5月6日成交额为113.27万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533617370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533617370?lang=zh_cn&edition=fundamental","pubTime":"2025-05-07 10:09","pubTimestamp":1746583786,"startTime":"0","endTime":"0","summary":"美东时间2025年5月6日,Mural Oncology Plc成交额为113.27万美元,成交额较昨日增加20.51%,当日成交量为44.85万股。Mural Oncology Plc于2025年5月6日跌1.18%,报2.51美元,该股过去5个交易日跌4.2%,年初至今跌22.05%,过去60日跌43.85%。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子,旨在捕获和扩大高剂量重组人IL - 2的治疗益处,同时减轻其标志性毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507100952a474b709&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507100952a474b709&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2532015804","title":"Mural Oncology Plc5月2日成交额为93.40万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532015804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532015804?lang=zh_cn&edition=fundamental","pubTime":"2025-05-03 10:08","pubTimestamp":1746238084,"startTime":"0","endTime":"0","summary":"美东时间2025年5月2日,Mural Oncology Plc成交额为93.40万美元,成交额较昨日减少7.82%,当日成交量为35.64万股。Mural Oncology Plc于2025年5月2日涨1.15%,报2.64美元,该股过去5个交易日涨1.54%,年初至今跌18.01%,过去60日跌35.14%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-02|93.40万|-7.82%|35.64万|#|2025-05-01|101.32万|9.55%|38.98万|#|2025-04-30|92.49万|-12.24%|35.17万|#|2025-04-29|105.38万|-11.41%|40.34万|#|2025-04-28|118.95万|4.91%|45.50万|Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503100808a47087cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503100808a47087cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2532010192","title":"Mural Oncology Plc4月30日成交额为92.49万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532010192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532010192?lang=zh_cn&edition=fundamental","pubTime":"2025-05-01 10:08","pubTimestamp":1746065315,"startTime":"0","endTime":"0","summary":"美东时间2025年4月30日,Mural Oncology Plc成交额为92.49万美元,成交额较昨日减少12.24%,当日成交量为35.17万股。Mural Oncology Plc于2025年4月30日涨0.38%,报2.63美元,该股过去5个交易日跌5.05%,年初至今跌18.32%,过去60日跌28.14%。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子,旨在捕获和扩大高剂量重组人IL - 2的治疗益处,同时减轻其标志性毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501100844a6cf8e96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501100844a6cf8e96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2531728073","title":"Mural Oncology Plc4月29日成交额为105.38万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531728073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531728073?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 10:07","pubTimestamp":1745978824,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日,Mural Oncology Plc成交额为105.38万美元,成交额较昨日减少11.41%,当日成交量为40.34万股。Mural Oncology Plc于2025年4月29日涨0.38%,报2.62美元,该股过去5个交易日跌3.68%,年初至今跌18.63%,过去60日跌30.13%。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子,旨在捕获和扩大高剂量重组人IL - 2的治疗益处,同时减轻其标志性毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430100712a46cfd22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430100712a46cfd22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2531921286","title":"Mural Oncology Plc4月28日成交额为118.95万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531921286","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531921286?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 10:06","pubTimestamp":1745892370,"startTime":"0","endTime":"0","summary":"美东时间2025年4月28日,Mural Oncology Plc成交额为118.95万美元,成交额较昨日增加4.91%,当日成交量为45.50万股。Mural Oncology Plc于2025年4月28日涨0.38%,报2.61美元,该股过去5个交易日跌2.97%,年初至今跌18.94%,过去60日跌30.77%。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子,旨在捕获和扩大高剂量重组人IL - 2的治疗益处,同时减轻其标志性毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429100614a6cc7eca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429100614a6cc7eca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2530111313","title":"Mural Oncology Plc4月25日成交额为113.38万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530111313","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530111313?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 10:05","pubTimestamp":1745633136,"startTime":"0","endTime":"0","summary":"美东时间2025年4月25日,Mural Oncology Plc成交额为113.38万美元,成交额较昨日减少45.98%,当日成交量为43.78万股。Mural Oncology Plc于2025年4月25日跌1.52%,报2.6美元,该股过去5个交易日跌3.7%,年初至今跌19.25%,过去60日跌30.11%。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子,旨在捕获和扩大高剂量重组人IL - 2的治疗益处,同时减轻其标志性毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426100545a6c8d0e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426100545a6c8d0e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2530948159","title":"Mural Oncology Plc4月24日成交额为209.89万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530948159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530948159?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 10:04","pubTimestamp":1745546689,"startTime":"0","endTime":"0","summary":"美东时间2025年4月24日,Mural Oncology Plc成交额为209.89万美元,成交额较昨日减少14.14%,当日成交量为79.00万股。Mural Oncology Plc于2025年4月24日跌4.69%,报2.64美元,该股过去5个交易日涨9.09%,年初至今跌18.01%,过去60日跌31.07%。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子,旨在捕获和扩大高剂量重组人IL - 2的治疗益处,同时减轻其标志性毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425100454a6c764ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425100454a6c764ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2529059087","title":"Mural Oncology Plc4月22日成交额为321.75万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529059087","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529059087?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 10:04","pubTimestamp":1745373850,"startTime":"0","endTime":"0","summary":"美东时间2025年4月22日,Mural Oncology Plc成交额为321.75万美元,成交额较昨日减少11.96%,当日成交量为118.25万股。Mural Oncology Plc于2025年4月22日涨1.12%,报2.72美元,该股过去5个交易日涨164.08%,年初至今跌15.53%,过去60日跌31.14%。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子,旨在捕获和扩大高剂量重组人IL - 2的治疗益处,同时减轻其标志性毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423100421a6c486f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423100421a6c486f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2529838213","title":"Mural Oncology Plc盘中异动 股价大跌5.19%报2.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529838213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529838213?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 23:57","pubTimestamp":1745251063,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日23时57分,Mural Oncology Plc股票出现异动,股价大幅下跌5.19%。截至发稿,该股报2.56美元/股,成交量79.95万股,换手率4.64%,振幅6.67%。Mural Oncology Plc股票所在的生物技术行业中,整体跌幅为0.22%。Mural Oncology Plc公司简介:Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421235743a4614487&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421235743a4614487&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":1},{"id":"2529154038","title":"本周解锁数据一览:UDS、VENOM及MURA等代币将于本周迎来一次性大额解锁","url":"https://stock-news.laohu8.com/highlight/detail?id=2529154038","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529154038?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 09:05","pubTimestamp":1745197500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//flash/290481","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_zh_live","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2528470044","title":"Mural Oncology Plc4月17日成交额为1520.35万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528470044","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528470044?lang=zh_cn&edition=fundamental","pubTime":"2025-04-18 10:07","pubTimestamp":1744942055,"startTime":"0","endTime":"0","summary":"美东时间2025年4月17日,Mural Oncology Plc成交额为1520.35万美元,成交额较昨日减少23.23%,当日成交量为576.50万股。Mural Oncology Plc于2025年4月17日涨11.57%,报2.7美元,该股过去5个交易日涨171.36%,年初至今跌16.15%,过去60日跌31.65%。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子,旨在捕获和扩大高剂量重组人IL - 2的治疗益处,同时减轻其标志性毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418100744a45d4a36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418100744a45d4a36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":1},{"id":"2528743925","title":"Mural Oncology Plc盘中异动 早盘股价大涨5.58%报2.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528743925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528743925?lang=zh_cn&edition=fundamental","pubTime":"2025-04-17 21:41","pubTimestamp":1744897301,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日21时41分,Mural Oncology Plc股票出现异动,股价大幅拉升5.58%。截至发稿,该股报2.56美元/股,成交量69.6749万股,换手率4.04%,振幅3.30%。Mural Oncology Plc股票所在的生物技术行业中,整体涨幅为0.43%。Mural Oncology Plc公司简介:Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041721414294d8d467&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041721414294d8d467&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":1},{"id":"2528088787","title":"Mural Oncology Plc4月16日成交额为1980.46万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528088787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528088787?lang=zh_cn&edition=fundamental","pubTime":"2025-04-17 10:04","pubTimestamp":1744855442,"startTime":"0","endTime":"0","summary":"美东时间2025年4月16日,Mural Oncology Plc成交额为1980.46万美元,成交额较昨日减少97.14%,当日成交量为816.28万股。Mural Oncology Plc于2025年4月16日涨0.41%,报2.42美元,该股过去5个交易日涨116.07%,年初至今跌24.84%,过去60日跌41.55%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-16|1980.46万|-97.14%|816.28万|#|2025-04-15|6.93亿|311927.31%|2.60亿|#|2025-04-14|22.20万|-3.03%|21.63万|#|2025-04-11|22.90万|-42.51%|22.43万|#|2025-04-10|39.82万|-42.73%|39.57万|Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417100411a6bd4a17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417100411a6bd4a17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":1},{"id":"2527407009","title":"Mural Oncology Plc4月15日成交额为6.93亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527407009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527407009?lang=zh_cn&edition=fundamental","pubTime":"2025-04-16 10:01","pubTimestamp":1744768896,"startTime":"0","endTime":"0","summary":"美东时间2025年4月15日,Mural Oncology Plc成交额为6.93亿美元,成交额较昨日增加311927.31%,当日成交量为2.60亿股。Mural Oncology Plc于2025年4月15日涨133.98%,报2.41美元,该股过去5个交易日涨121.1%,年初至今跌25.16%,过去60日跌39.75%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-15|6.93亿|311927.31%|2.60亿|#|2025-04-14|22.20万|-3.03%|21.63万|#|2025-04-11|22.90万|-42.51%|22.43万|#|2025-04-10|39.82万|-42.73%|39.57万|#|2025-04-09|69.54万|91.65%|65.49万|Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416100138a45a70fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416100138a45a70fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":45,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MURA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MURA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MURA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.3333,"hold":0.6667,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6667,"analysts":3,"updateTime":1742961600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MURA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MURA","date":"2025-07-03","current":-0.340797,"percent":0.567416,"low":-0.567064,"twenty":-0.411715,"median":-0.34988,"eighty":-0.308624,"high":-0.133414,"avg":-0.356655,"sd":0.071391,"marketCap":44553712},"quantilePoints":[{"date":"2024-01-05","current":-0.481599,"twenty":-0.478881,"median":-0.474804,"eighty":-0.470727,"marketCap":94630786},{"date":"2024-01-12","current":-0.410251,"twenty":-0.486355,"median":-0.471406,"eighty":-0.445585,"marketCap":80611410},{"date":"2024-01-19","current":-0.3423,"twenty":-0.481599,"median":-0.439979,"eighty":-0.393263,"marketCap":67259623},{"date":"2024-01-26","current":-0.394962,"twenty":-0.471406,"median":-0.400483,"eighty":-0.374577,"marketCap":77607258},{"date":"2024-02-02","current":-0.377974,"twenty":-0.468009,"median":-0.394962,"eighty":-0.374577,"marketCap":74269311},{"date":"2024-02-09","current":-0.361836,"twenty":-0.439979,"median":-0.387742,"eighty":-0.372878,"marketCap":71098262},{"date":"2024-02-16","current":-0.422992,"twenty":-0.422992,"median":-0.393263,"eighty":-0.372878,"marketCap":83114870},{"date":"2024-02-23","current":-0.394962,"twenty":-0.419594,"median":-0.394962,"eighty":-0.374237,"marketCap":77607258},{"date":"2024-03-01","current":-0.449322,"twenty":-0.440489,"median":-0.397934,"eighty":-0.375256,"marketCap":88288687},{"date":"2024-03-08","current":-0.463762,"twenty":-0.455438,"median":-0.398359,"eighty":-0.376785,"marketCap":91125942},{"date":"2024-03-15","current":-0.409401,"twenty":-0.455438,"median":-0.402181,"eighty":-0.377804,"marketCap":80444513},{"date":"2024-03-22","current":-0.371179,"twenty":-0.454589,"median":-0.401757,"eighty":-0.376785,"marketCap":72934133},{"date":"2024-03-28","current":-0.403798,"twenty":-0.451361,"median":-0.400058,"eighty":-0.375086,"marketCap":83766622},{"date":"2024-04-05","current":-0.375246,"twenty":-0.449322,"median":-0.398359,"eighty":-0.374978,"marketCap":77843730},{"date":"2024-04-12","current":-0.350774,"twenty":-0.445245,"median":-0.39751,"eighty":-0.372198,"marketCap":72766965},{"date":"2024-04-19","current":-0.291224,"twenty":-0.441508,"median":-0.394962,"eighty":-0.366932,"marketCap":60413503},{"date":"2024-04-26","current":-0.287961,"twenty":-0.440319,"median":-0.393263,"eighty":-0.354313,"marketCap":59736601},{"date":"2024-05-03","current":-0.311618,"twenty":-0.439979,"median":-0.38392,"eighty":-0.342979,"marketCap":64644141},{"date":"2024-05-10","current":-0.309986,"twenty":-0.43845,"median":-0.382221,"eighty":-0.327769,"marketCap":64305690},{"date":"2024-05-17","current":-0.343069,"twenty":-0.428768,"median":-0.378823,"eighty":-0.318307,"marketCap":65833885},{"date":"2024-05-24","current":-0.316611,"twenty":-0.420444,"median":-0.375426,"eighty":-0.318307,"marketCap":60756722},{"date":"2024-05-31","current":-0.295445,"twenty":-0.417386,"median":-0.374577,"eighty":-0.316082,"marketCap":56694991},{"date":"2024-06-07","current":-0.294563,"twenty":-0.413309,"median":-0.372878,"eighty":-0.310639,"marketCap":56525752},{"date":"2024-06-14","current":-0.291035,"twenty":-0.410081,"median":-0.371179,"eighty":-0.308355,"marketCap":55848797},{"date":"2024-06-21","current":-0.286626,"twenty":-0.409401,"median":-0.368234,"eighty":-0.301829,"marketCap":55002603},{"date":"2024-06-28","current":-0.270751,"twenty":-0.409061,"median":-0.366932,"eighty":-0.301173,"marketCap":51956305},{"date":"2024-07-05","current":-0.264578,"twenty":-0.407601,"median":-0.361535,"eighty":-0.298647,"marketCap":50771634},{"date":"2024-07-12","current":-0.28839,"twenty":-0.40373,"median":-0.353221,"eighty":-0.295445,"marketCap":55341081},{"date":"2024-07-15","current":-0.28839,"twenty":-0.403661,"median":-0.351997,"eighty":-0.295445,"marketCap":55341081},{"date":"2024-08-02","current":-0.30691,"twenty":-0.403593,"median":-0.350774,"eighty":-0.295445,"marketCap":58895095},{"date":"2024-08-09","current":-0.28839,"twenty":-0.402946,"median":-0.34384,"eighty":-0.294206,"marketCap":55341081},{"date":"2024-08-16","current":-0.309698,"twenty":-0.402097,"median":-0.3423,"eighty":-0.293345,"marketCap":53669674},{"date":"2024-08-23","current":-0.322479,"twenty":-0.400738,"median":-0.337815,"eighty":-0.294206,"marketCap":55884613},{"date":"2024-08-30","current":-0.320512,"twenty":-0.399365,"median":-0.334277,"eighty":-0.294563,"marketCap":55543853},{"date":"2024-09-06","current":-0.314613,"twenty":-0.398685,"median":-0.332486,"eighty":-0.294916,"marketCap":54521574},{"date":"2024-09-13","current":-0.309698,"twenty":-0.398359,"median":-0.332045,"eighty":-0.295445,"marketCap":53669674},{"date":"2024-09-20","current":-0.340176,"twenty":-0.398359,"median":-0.331604,"eighty":-0.295445,"marketCap":58951452},{"date":"2024-09-27","current":-0.2979,"twenty":-0.398019,"median":-0.327395,"eighty":-0.295798,"marketCap":51625115},{"date":"2024-10-04","current":-0.314613,"twenty":-0.396762,"median":-0.323462,"eighty":-0.296327,"marketCap":54521574},{"date":"2024-10-11","current":-0.336243,"twenty":-0.395369,"median":-0.327395,"eighty":-0.296327,"marketCap":58269932},{"date":"2024-10-18","current":-0.362789,"twenty":-0.394962,"median":-0.331327,"eighty":-0.296956,"marketCap":62870190},{"date":"2024-10-25","current":-0.343125,"twenty":-0.394282,"median":-0.332398,"eighty":-0.2979,"marketCap":59462592},{"date":"2024-10-31","current":-0.350008,"twenty":-0.393263,"median":-0.332486,"eighty":-0.298033,"marketCap":60655251},{"date":"2024-11-08","current":-0.33231,"twenty":-0.391781,"median":-0.332486,"eighty":-0.298629,"marketCap":57588412},{"date":"2024-11-15","current":-0.387645,"twenty":-0.387286,"median":-0.33396,"eighty":-0.298901,"marketCap":59610428},{"date":"2024-11-22","current":-0.374316,"twenty":-0.385465,"median":-0.33526,"eighty":-0.298973,"marketCap":57560786},{"date":"2024-11-29","current":-0.443181,"twenty":-0.393263,"median":-0.336243,"eighty":-0.298973,"marketCap":68150604},{"date":"2024-12-06","current":-0.455399,"twenty":-0.39564,"median":-0.339193,"eighty":-0.299866,"marketCap":70029443},{"date":"2024-12-13","current":-0.415413,"twenty":-0.398359,"median":-0.339541,"eighty":-0.300736,"marketCap":63880516},{"date":"2024-12-20","current":-0.348769,"twenty":-0.398359,"median":-0.340176,"eighty":-0.301829,"marketCap":53632305},{"date":"2024-12-27","current":-0.353212,"twenty":-0.398359,"median":-0.340176,"eighty":-0.301829,"marketCap":54315519},{"date":"2025-01-03","current":-0.355433,"twenty":-0.398359,"median":-0.34173,"eighty":-0.302962,"marketCap":54657126},{"date":"2025-01-10","current":-0.405416,"twenty":-0.398359,"median":-0.343097,"eighty":-0.304593,"marketCap":62343284},{"date":"2025-01-17","current":-0.409859,"twenty":-0.401077,"median":-0.344248,"eighty":-0.306233,"marketCap":63026498},{"date":"2025-01-24","current":-0.435406,"twenty":-0.40373,"median":-0.345715,"eighty":-0.306728,"marketCap":66954979},{"date":"2025-01-31","current":-0.418745,"twenty":-0.408369,"median":-0.346075,"eighty":-0.30678,"marketCap":64392927},{"date":"2025-02-07","current":-0.492053,"twenty":-0.409859,"median":-0.34988,"eighty":-0.307074,"marketCap":75665959},{"date":"2025-02-14","current":-0.473171,"twenty":-0.413191,"median":-0.351865,"eighty":-0.307731,"marketCap":72762299},{"date":"2025-02-21","current":-0.468728,"twenty":-0.415413,"median":-0.353212,"eighty":-0.307731,"marketCap":72079085},{"date":"2025-02-28","current":-0.406527,"twenty":-0.418745,"median":-0.354323,"eighty":-0.308355,"marketCap":62514088},{"date":"2025-03-07","current":-0.39653,"twenty":-0.416524,"median":-0.35567,"eighty":-0.308355,"marketCap":60976856},{"date":"2025-03-14","current":-0.486438,"twenty":-0.418745,"median":-0.357655,"eighty":-0.308355,"marketCap":62514088},{"date":"2025-03-21","current":-0.518803,"twenty":-0.425409,"median":-0.358364,"eighty":-0.309698,"marketCap":66673486},{"date":"2025-03-28","current":-0.180978,"twenty":-0.428742,"median":-0.357873,"eighty":-0.308355,"marketCap":23258192},{"date":"2025-04-04","current":-0.164891,"twenty":-0.425409,"median":-0.357272,"eighty":-0.30691,"marketCap":21190797},{"date":"2025-04-11","current":-0.133414,"twenty":-0.422992,"median":-0.355433,"eighty":-0.303717,"marketCap":17145595},{"date":"2025-04-17","current":-0.32442,"twenty":-0.42226,"median":-0.354323,"eighty":-0.301829,"marketCap":41692464},{"date":"2025-04-25","current":-0.353912,"twenty":-0.421188,"median":-0.355237,"eighty":-0.303339,"marketCap":45482688},{"date":"2025-05-02","current":-0.349891,"twenty":-0.419189,"median":-0.353912,"eighty":-0.305469,"marketCap":44965839},{"date":"2025-05-09","current":-0.347209,"twenty":-0.418745,"median":-0.353217,"eighty":-0.30656,"marketCap":44621273},{"date":"2025-05-16","current":-0.333407,"twenty":-0.416968,"median":-0.353212,"eighty":-0.306743,"marketCap":43587576},{"date":"2025-05-23","current":-0.363252,"twenty":-0.415635,"median":-0.353567,"eighty":-0.306878,"marketCap":47489422},{"date":"2025-05-30","current":-0.348722,"twenty":-0.415413,"median":-0.353217,"eighty":-0.307403,"marketCap":45589845},{"date":"2025-06-06","current":-0.339476,"twenty":-0.415373,"median":-0.352957,"eighty":-0.307731,"marketCap":44381024},{"date":"2025-06-13","current":-0.334192,"twenty":-0.414053,"median":-0.351901,"eighty":-0.308105,"marketCap":43690268},{"date":"2025-06-20","current":-0.326267,"twenty":-0.413191,"median":-0.350402,"eighty":-0.308355,"marketCap":42654136},{"date":"2025-06-27","current":-0.327587,"twenty":-0.412747,"median":-0.349891,"eighty":-0.308355,"marketCap":42826824},{"date":"2025-07-03","current":-0.340797,"twenty":-0.411715,"median":-0.34988,"eighty":-0.308624,"marketCap":44553712}],"updateTime":1751790154221}}}